Total Payments
$10,261
2024 Payments
$3,074
Companies
26
Transactions
690
Medicare Patients
5,698
Medicare Billing
$453,360
Payment Breakdown by Category
Food & Beverage$9,499 (92.6%)
Education$762.72 (7.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,499 | 679 | 92.6% |
| Education | $762.72 | 11 | 7.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,734 | 189 | $0 (2024) |
| UCB, Inc. | $910.10 | 124 | $0 (2024) |
| Janssen Biotech, Inc. | $875.29 | 58 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $730.82 | 21 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $725.22 | 40 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $613.54 | 37 | $0 (2024) |
| LEO Pharma Inc. | $513.16 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $463.03 | 30 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $445.95 | 42 | $0 (2024) |
| Lilly USA, LLC | $423.79 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,074 | 208 | ABBVIE INC. ($836.37) |
| 2023 | $2,410 | 166 | ABBVIE INC. ($410.40) |
| 2022 | $2,366 | 149 | ABBVIE INC. ($888.24) |
| 2021 | $2,411 | 167 | AbbVie Inc. ($599.06) |
All Payment Transactions
690 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.89 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.92 | General |
| Category: Immunology | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Immunology | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.46 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,620 | 3,675 | $822,943 | $124,049 |
| 2022 | 15 | 1,653 | 3,591 | $373,039 | $122,245 |
| 2021 | 17 | 1,465 | 3,084 | $368,600 | $131,255 |
| 2020 | 13 | 960 | 2,122 | $238,255 | $75,811 |
Total Patients
5,698
Total Services
12,472
Medicare Billing
$453,360
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 330 | 619 | $259,980 | $39,505 | 15.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 445 | 668 | $212,424 | $33,201 | 15.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 229 | 472 | $115,640 | $14,490 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 144 | $64,224 | $10,250 | 16.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 140 | 164 | $32,964 | $5,432 | 16.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 185 | 1,336 | $33,400 | $5,123 | 15.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 35 | 52 | $25,376 | $3,728 | 14.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $22,794 | $3,371 | 14.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 15 | 27 | $16,659 | $2,794 | 16.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $9,894 | $1,636 | 16.5% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 18 | 19 | $8,626 | $1,363 | 15.8% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 12 | 17 | $8,636 | $1,221 | 14.1% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 14 | $7,182 | $1,087 | 15.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 24 | $4,968 | $809.31 | 16.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 44 | $176.00 | $37.60 | 21.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 346 | 616 | $117,656 | $38,865 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 382 | 550 | $64,350 | $27,835 | 43.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 216 | 416 | $56,160 | $12,013 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 170 | $30,260 | $11,877 | 39.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 176 | 1,371 | $26,049 | $5,265 | 20.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 135 | 152 | $11,096 | $5,163 | 46.5% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 33 | 55 | $12,320 | $4,154 | 33.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 79 | 79 | $14,457 | $4,123 | 28.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 15 | 35 | $11,935 | $3,090 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $8,062 | $2,520 | 31.3% |
About Michele Parkhill, PA-C
Michele Parkhill, PA-C is a Physician Assistant healthcare provider based in Schnecksville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2010. The National Provider Identifier (NPI) number assigned to this provider is 1124335567.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michele Parkhill, PA-C has received a total of $10,261 in payments from pharmaceutical and medical device companies, with $3,074 received in 2024. These payments were reported across 690 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($9,499).
As a Medicare-enrolled provider, Parkhill has provided services to 5,698 Medicare beneficiaries, totaling 12,472 services with total Medicare billing of $453,360. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Schnecksville, PA
- Active Since 09/07/2010
- Last Updated 08/29/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1124335567
Products in Payments
- SKYRIZI (Biological) $1,435
- RINVOQ (Biological) $994.46
- DUPIXENT (Biological) $922.70
- TREMFYA (Drug) $848.25
- NUZYRA (Drug) $613.54
- Cimzia (Drug) $575.11
- ADBRY (Biological) $476.70
- ILUMYA (Biological) $451.35
- Sotyktu (Drug) $445.95
- TALTZ (Drug) $382.26
- Otezla (Drug) $379.78
- Bimzelx (Biological) $334.99
- HUMIRA (Biological) $266.89
- COSENTYX (Drug) $157.68
- EUCRISA (Drug) $156.94
- XOLAIR (Drug) $138.24
- VTAMA (Drug) $137.78
- CIBINQO (Drug) $120.83
- Ilumya (Biological) $116.65
- COSENTYX (Biological) $98.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.